Opinion
Video
Author(s):
Experts on atopic dermatitis weigh the risks and rewards of systemic treatments for pregnant patients and provide clinical insights on monitoring for adverse effects associated with dupilumab.
What’s Next for Topical JAK Inhibitors?
The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
What’s New in the Medicine Cabinet: AD and Ocular Comorbidities
The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
Pediatric Patients with Atopic Dermatitis Have Lower SCH and Higher TEWL, Compared to Those Without
Limited Evidence Supporting the Efficacy of Antifungals for Atopic Dermatitis